Navigation Links
Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
Date:6/21/2009

Pixantrone is also now available in Europe on a named-patient basis.

About Pixantrone

Pixantrone (BBR 2778), is a novel major groove binder with an aza-anthracenedione molecular structure that differentiates it from the anthracyclines and other related chemotherapy agents. Anthracyclines are the cornerstone therapeutic for the treatment of lymphoma, leukemia, and breast cancer. Although they are sufficiently effective to be used as first-line (initial) treatment, they cause cumulative heart damage that may result in congestive heart failure many years later. As a result, there is a lifetime limit of anthracycline doses and most patients who previously have been treated with an anthracycline are not able to receive further anthracycline treatment if their disease returns. It also can be administered through a peripheral vein rather than a central implanted catheter as required for other drugs in this class.

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit www.CellTherapeutics.com.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_news

This press release includes forward-looking statements that involve a number of risks and uncertainties, the outcome of which could materially and/or adversely affect actual future results and the trading price of CTI's securities, including whether CTI will become profitable and the development of pixantrone. Specifically, the risks and uncertainties that could affect the development of pixantrone include risks associated with preclinical and
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Preclinical Study Presented at AACR Annual Meeting Shows Peregrines Anti-PS Immunocytokines Can Generate Protective Immune Responses in a Highly Aggressive Breast Cancer Model
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Micromets BiTE Antibody Blinatumomab (MT103/MEDI-538) Demonstrates Durable Responses in Patients with Relapsed Non-Hodgkins Lymphoma
4. SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
5. Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
6. Use it or Lose it: A New Theory About Preserving Erectile Function After Prostate Surgery
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Post-Hoc Data Show Daily Activity Participation, Independence and Sleep Quality Improved in Adults with Moderate to Severe Rheumatoid Arthritis After Treatment with ORENCIA(R) (Abatacept)
9. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
10. AHF Seeks White House Clarification After Press Room Flap Over CDCs HIV Numbers
11. New Implantable Lenses Can Reduce the Need for Glasses After Cataract Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Concord Medical Services Holdings ... CCM ), a leading specialty hospital management solution provider ... diagnostic imaging centers in China , ... of Directors declared a special cash dividend of US$0.30 ... ("ADS")) on the Company,s outstanding ordinary shares. The total ...
(Date:7/28/2014)... 28, 2014   Cardioxyl Pharmaceuticals, Inc. announced ... that CXL-1427, a novel potential treatment for acute decompensated ... The company has now initiated dosing of hospitalized patients ... trial designed to further evaluate the drug,s safety and ... The Phase I clinical trial evaluated the safety and ...
(Date:7/28/2014)... 28, 2014  Isis Pharmaceuticals, Inc. (NASDAQ: ... 2014 Financial Results and Highlights Conference CallWhen:Monday, August 4 ... How:Live on the Internet. Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
Breaking Medicine Technology:Concord Medical Declares Special Dividend 2Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2014 Financial Results Conference Call 2
... Technologies Inc., the leading developer of non-invasive electrocardiographic ... $7.5 million Series "C" financing.  The proceeds from ... commercial efforts related to its ECVUE ™ ... (Logo: http://photos.prnewswire.com/prnh/20110531/DC10432LOGO ) CardioInsight recently ...
...  MAKScientific, LLC, a privately held company focused on the ... that it has entered into an exclusive, worldwide option ... BIIB ) to develop and commercialize drug candidates for ... diseases. Under the agreement, Biogen Idec will ...
Cached Medicine Technology:CardioInsight Announces Closing of $7.5 Million Equity Financing 2
(Date:7/28/2014)... to accept the diagnosis "growing pains" when they complained ... involving 3,000 adolescents has now shown that the knee ... the study that one in three young people between ... pain in their knees. Seven percent of the adolescents ... knee," says physiotherapist and PhD Michael Skovdal Rathleff from ...
(Date:7/28/2014)... WASHINGTON, July 28, 2014A group of researchers in Taiwan ... able to detect an early complication of diabetes sooner, ... proves safe and effective in clinical trials, it may ... effective treatment of this complication, called diabetic autonomic neuropathy, ... and Type 2 diabetes. The condition progressively affects the ...
(Date:7/28/2014)... new study of the European project SOPHIE has ... policies and gender inequalities in health in Europe. ... policies (central and southern Europe) and countries with ... self-perceived health, i.e. women reported poorer health than ... Europe countries, where women present a 27% higher ...
(Date:7/28/2014)... Northridge, CA (PRWEB) July 28, 2014 ... a $100 coupon for new patients. Finding a new dentist ... anxiety or dental issues that have gone untreated and worry ... provider. Dr. Ariz specializes in patients with special concerns and ... patients feels comfortable and right at home. This special coupon ...
(Date:7/28/2014)... Australia (PRWEB) July 28, 2014 What ... a happier lifestyle can often be a struggle that ... channel, psychic and medium, Lynette Leckie-Clark provides simple how-to ... book “The Magic of You.” With inspiring spiritual affirmations ... you can find empowerment, confidence and motivation for everyday ...
Breaking Medicine News(10 mins):Health News:Many people never grow out of their growing pains 2Health News:Wearable device for the early detection of common diabetes-related neurological condition 2Health News:Gender inequalities in health: A matter of policies 2Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:Be Empowered to Achieve Happiness from New Book "The Magic of You" 2
... up to Take Control of Health, Take off Pounds to ... Gain ... a year makes!,What a difference people can make when they join together ... Washington,D.C. to join Dr. Ian Smith, Patti LaBelle, Yolanda Adams, Michael Strahan,Steve ...
... a,Washington, D.C.-based research, evaluation and consulting organization,today released ... finds,low awareness and knowledge levels about HIV/AIDS, but ... important predictors for heightened,awareness., Some key findings ... -- Only 1 percent of respondents were ...
... April 2, 2008 The Richard B. and,Lynne V. ... the Institute,s Board of Directors. As a director, she ... "We are delighted to have Mary Cheney join ... of the Cheney family,actively involved in shaping the major ...
... Oaks,Development Group announced today the company has closed on ... behind St. David Medical Center in Austin,Texas. A 29,724-square-foot ... being converted to Oaks, unique tenant-ownership model., Oaks, ... limited liability,company (L.L.C.). Tenant partners split ownership interest of ...
... Sky,One Medical, Inc. (OTC Bulletin Board: CSKI) ("China Sky ... pharmaceutical,medicinal and diagnostic products in China, today announced record,financial ... December 31,2007., Fourth Quarter 2007 Highlights ... from the fourth quarter of ...
... stalled at just 9 percent, HARTFORD, Conn., April ... need to re-examine its value proposition to break,out of ... broader market,according to a new study by Conning Research ... sold primarily by specialist agents,to a niche market of ...
Cached Medicine News:Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 2Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 3Health News:50 Million Pound Challenge Marks 1st Anniversary - What a Difference a Year Makes! 4Health News:Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says 2Health News:Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says 3Health News:Mary Cheney Joins the Cheney Cardiovascular Institute Board of Directors 2Health News:Oaks Development Group Acquires Medical Office Building in Austin, Texas 2Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 2Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 3Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 4Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 5Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 6Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 7Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 8Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 9Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 10Health News:China Sky One Medical, Inc. Announces Record Fourth Quarter and Fiscal Year 2007 Results 11Health News:Conning Research: Long Term Care Insurance Industry Continues to Search for Broader Market 2
... 300 watt xenon Light ... Endoscopy shares your commitment to ... highest quality care available through ... of advanced surgical instruments and ...
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
The new X7000 light source is specifically tuned for the demanding requirements of Progressive Scan High Definition. The X7000 Lightsource uses a 300 Watt Xenon Elliptical Bulb for crystal clear illu...
... STORZ has brought arthroscopic shaver systems to ... the introduction of the Powershaver SL. Just ... the market leader in surgical endoscopy, the ... important and highly specialized field of arthroscopic ...
Medicine Products: